Mirae Asset Global Etfs Holdings Ltd. Biocryst Pharmaceuticals Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 113,527 shares of BCRX stock, worth $887,781. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,527Holding current value
$887,781% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCRX
# of Institutions
264Shares Held
176MCall Options Held
410KPut Options Held
444K-
Vanguard Group Inc Valley Forge, PA20.3MShares$159 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$156 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$98.3 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$73.1 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$69 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.45B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...